# New Animal Drugs; Enrofloxacin
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2008-04-23 · Effective 2008-04-23 · 73 FR 21819
## Document
- **Document number:** E8-8713
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 21819
- **CFR reference:** 21 CFR 522
- **Publication date:** 2008-04-23
- **Effective date:** 2008-04-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for use of enrofloxacin injectable solution in swine for the treatment and control of respiratory disease.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/04/23/E8-8713/new-animal-drugs-enrofloxacin)
---
*AI Analytics · CC0 1.0*